← Open Payments lookup

TANIA ABOUSAID: Open Payments

NPI 1295317725 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,211 in 59 payments from 16 companies in 2025. Trend: 2023 $940 · 2024 $1,229 · 2025 $1,211

Food & beverage: $1,211
CompanyPaymentsAmount
ABBVIE INC.20$370
Novo Nordisk Inc9$206
Regeneron Healthcare Solutions, Inc.4$94
AstraZeneca Pharmaceuticals LP5$92
GENZYME CORPORATION3$84
GlaxoSmithKline, LLC.2$51
Sumitomo Pharma America, Inc.2$51
Hologic Sales and Service, LLC2$43
Boehringer Ingelheim Pharmaceuticals, Inc.2$41
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$39

Products named: QULIPTA, DUPIXENT, Ozempic, Rybelsus, UBRELVY, BREZTRI, VRAYLAR, TRELEGY ELLIPTA.

Industry payments across NY — which companies pay providers there.